Use of glatiramer acetate

PheWeb

MSMED_GLATIRAMERACETATE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L03AX13

458

Check pre-conditions, main-only, mode, ICD version None

377

Check minimum number of events

Min. number of events 3

377

Include endpoints None

377

MSMED_GLATIRAMERACETATE

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Use of glatiramer acetate based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	364	296	68
Unadjusted prevalence (%)	0.12	0.17	0.05
Mean age at first event (years)	39.66	38.92	42.85

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: MSMED_GLATIRAMERACETATE – Use of glatiramer acetate
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of glatiramer acetate
after Use of glatiramer acetate

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Use of glatiramer acetate

↥